A study on the peripheral blood of MS patients demonstrated that peripheral pro-inflammatory B cells, defined by the cell surface marker CD19 and by secretion of the cytokine TNF-α, are significantly increased in all subtypes of MS, particularly those with PPMS (15). The gene discussed is CD19; the disease is myeloid sarcoma.